Enteral Feeding Devices Market is expected to reach US$ 4090.70 million by 2028

The enteral feeding devices market is expected to reach at  US$ 4090.70 million by 2028; registering at a CAGR of 5.75% from 2022 to 2028, according to a new research study conducted by The Insight partners

Enteral Feeding Pumps Segment to Account for Largest Share in Enteral Feeding Devices Market During 2022–2028

The report highlights the key factors driving the enteral feeding devices market growth and prominent players with their developments in the market.

Based on product, the enteral feeding devices market is segmented into enteral feeding tubes, enteral feeding pumps, administration sets, enteral syringes, and consumables. The enteral feeding pumps segment held the largest share of the market in 2022, and the enteral feeding tubes segment is expected to register the highest CAGR during the forecast period. Based on application, the enteral feeding devices market is segmented into oncology, gastrointestinal diseases, neurological disorders, diabetes, hypermetabolism, and other applications. The oncology segment held the largest share of the market in 2022, and it is expected to register the highest CAGR during the forecast period. Based on material, the enteral feeding devices market is segmented into polyvinylchloride (PVC), polyurethane, and silicone. The polyvinyl chloride segment held the largest share of the market in 2022. Based on age group, the enteral feeding devices market is bifurcated into adults and pediatrics. The adult segment held a larger share of the market in 2022. Based on end user, the enteral feeding devices market is segmented into hospitals, ambulatory surgical centers, and home care settings. The hospitals segment held the largest share of the market in 2022; however, the home care settings segment is expected to register the highest CAGR during the forecast period.

Global Enteral Feeding Devices Market, by Region, 2022 (%)

Source: The Insight Partners Analysis

The physicians adopt enteral feeding procedures in case of indications such as swallowing disorders, stroke or head injury, head and neck cancer, gastrointestinal malabsorption, cancer, neurological disorders, and gastrointestinal diseases. For instance, the American Cancer Society reported ~333,680 new cases of cancer related to the digestive system in the US in 2020. Enteral feeding products and services are highly used to administer nutrition to the patients. Thus, the increasing incidences of chronic diseases lead to several opportunities for the enteral feeding device market growth during the forecast period.

Abbott, B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical LLC, Danone SA, Moog Inc., Owens & Minor Inc., Cardinal Health Inc., NESTLé S.A., and Fresenius Kabi AG are among the leading companies operating in the global enteral feeding devices market.

Various organic and inorganic strategies are adopted by companies operating in the global enteral feeding devices market. Organic strategies mainly include product launches and product approvals. Further, acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth. Further, acquisition and partnership strategies help the market players strengthen their customer base and expand their product portfolios.

A few of the significant developments by key players in the global enteral feeding devices market are listed below.

• In May 2018, Owens & Minor Inc. acquired the surgical and infection prevention business of Halyard Health. As a result of this acquisition, Owens & Minor took a significant step in transforming the business into a global healthcare solutions provider. This acquisition has added a larger scale of business advantages to Owens & Minor’s existing product portfolio and helped expand the company’s addressable markets.
• In July 2017, Cardinal Health acquired the patient recovery business of Medtronic. The patient recovery business comprises patient care, deep vein thrombosis, and the nutritional insufficiency business of Medtronic. The acquired business of Medtronic includes ~23 product categories across various markets. This acquisition has added different popular brands such as Curity, Kendall, Dover, Argyle, and Kangaroo to the product portfolio of the company. 

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com